47.       Whitsed H, McCarthy WH, Hersey P. Nephelometric detection of circulating immune complexes using monoclonal rheumatoid factor. J Immunol Methods 1979;29:311-21.

46.       Thompson JF, Gee DC, Little JM. The carcinoid tumour. Aust N Z J Surg 1979;49:317-26.

45.       Shaw HM, Milton GW, McCarthy WH, Farago GA, Dilworth P. Effect of smoking on the recurrence of malignant melanoma. Med J Aust 1979;1:208-9.

44.       McGovern VJ, Shaw HM, Milton GW, Farago GA. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979;3:385-93.

43.       Hersey P, Murray E, Werkmeister J, McCarthy WH. Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays. Br J Cancer 1979;40:615-27.

42.       Hersey P, Edwards A, Trilivas C, Shaw H, Milton GW. Relationship of natural killer-cell activity to rhesus antigens in man. Br J Cancer 1979;39:234-40.

41.       Hersey P, Edwards A, Honeyman M, McCarthy WH. Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 1979;40:113-22.

40.       Shaw HM, Milton GW, Farago G, McCarthy WH. Endocrine influences on survival from malignant melanoma. Cancer 1978;42:669-77.

39.       Milton GW, McCarthy WH. Chemotherapy for malignant melanoma: a brief review and personal experience. Aust N Z J Surg 1978;48:53-5.

38.       McCarthy WH, Shaw HM, Milton GW. Spontaneous regression of metastatic malignant melanoma. Clin Oncol 1978;4:203-7.

37.       McCarthy WH, Shaw HM, Jones PH. Laser surgery for malignant melanoma and superficial malignancies. Aust N Z J Surg 1978;48:656-61.

36.       Hershey P, Edwards A, Milton GW, McCarthy WH. Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients. Br J Cancer 1978;37:505-13.

35.       Hersey P, Edwards AE, Murray E, McCarthy WH, Milton GW. Sequential studies of melanoma leukocyte-dependent antibody activity in melanoma patients. Eur J Cancer 1978;14:629-37.

34.       Shaw HM, McCarthy WH, Milton GW. Changing trends in mortality from malignant melanoma. Med J Aust 1977;2:77-80.

33.       Murray E, McCarthy WH, Hersey P. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients. Br J Cancer 1977;36:7-14.

32.       Morgan G, McCarthy WH, Hersey P. Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays. Br J Cancer 1977;36:446-52.

31.       Milton GW, Shaw HM, McCarthy WH. Occult primary malignant melanoma: factors influencing survival. Br J Surg 1977;64:805-8.

30.       McCarthy WH, Donaldson EJ, Hollows FC. What should we teach? A consensus method to determine curriculum content. Med Educ 1977;11:249-56.

29.       Landers MB, 3rd, Shaw HE, Jr., Anderson WB, Jr., Sinyai AJ. Argon laser treatment of central serous chorioretinopathy. Ann Ophthalmol 1977;9:1567-72.

28.       Hersey P, Morgan G, Stone DE, McCarthy WH, Milton GW. Previous pregnancy as a protective factor against death from melanoma. Lancet 1977;1:451-2.

27.       Hersey P, McCarthy WH. Immunotherapy of solid tumours. Aust N Z J Surg 1977;47:701-6.

26.       Hersey P, Honeyman M, Edwards A, Adams E, McCarthy WH. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer 1976;18:564-73.

25.          Boland SL, Shaw HM, Milton GW. Multiple primary cancers in patients with malignant melanoma. Med J Aust 1976;1:517-9.